SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-076246
Filing Date
2015-11-05
Accepted
2015-11-05 16:11:42
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-17874_110q.htm 10-Q 1001510
2 EX-31.1 a15-17874_1ex31d1.htm EX-31.1 11221
3 EX-31.2 a15-17874_1ex31d2.htm EX-31.2 11747
4 EX-32 a15-17874_1ex32.htm EX-32 9853
  Complete submission text file 0001104659-15-076246.txt   5102362

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT thrx-20150930.xml EX-101.INS 1117789
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrx-20150930.xsd EX-101.SCH 46819
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT thrx-20150930_cal.xml EX-101.CAL 54185
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT thrx-20150930_lab.xml EX-101.LAB 429148
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrx-20150930_pre.xml EX-101.PRE 295685
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT thrx-20150930_def.xml EX-101.DEF 161205
Mailing Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6502389600
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 151200751
SIC: 2834 Pharmaceutical Preparations